Strategies of therapeutic complement inhibition

This publication has 173 references indexed in Scilit:

• Bacterial expression and membrane targeting of the rat complement regulator Crry: A new model anticomplement therapeutic
  Protein Science, 2008
• Identification of a Potent and Orally Active Non-peptide C5a Receptor Antagonist
  Published by Elsevier ,2002
• The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies
  European Journal of Immunology, 2002
• Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-lifein vivo
  Clinical and Experimental Immunology, 2002
• Identification of Human Mannose Binding Lectin (MBL) Recognition Sites for Novel Inhibitory Antibodies
  Hybridoma and Hybridomics, 2002
• INHIBITION OF HYPERACUTE TRANSPLANT REJECTION BY SOLUBLE PROTEINS WITH THE FUNCTIONAL DOMAINS OF CD46 AND Fc??RII1
  Transplantation, 2000
• Function of Human Factor H and I on Xenosurface
  Biochemical and Biophysical Research Communications, 1999
• Effects of anti‐C5a monoclonal antibodies on oxygen use in a porcine model of severe sgifis
  European Journal of Clinical Investigation, 1998
• A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway
  European Journal of Immunology, 1996
• A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitro
  European Journal of Immunology, 1996